Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Protagonist Therapeutics (PTGX) Ownership Overview
1.33% Insiders
17.51% Mutual Funds
11.64% Other Institutional Investors
24.27% ETFs
45.25% Public Companies and
Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 53.42% of the company’s stock is owned by Institutional Investors, 1.33% is owned by Insiders, and 45.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 18, 2026 | xxxxxxxxxxxxx | $1483560 | |
Feb 06, 2026 | xxxxxxxxxxxxx | $1673600 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $4063743 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $3841037 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $1100484 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $5687056 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $8734000 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $96001507 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,863,016 | Institution | 10.98% | 559,267,174 | |
| 6,196,006 | Institution | 9.91% | 504,912,529 | |
| 4,465,973 | Institution | 7.14% | 363,932,140 | |
| 2,572,947 | Institution | 4.12% | 209,669,451 | |
| 2,126,265 | Institution | 3.40% | 173,269,335 | |
| 1,438,247 | Institution | 2.30% | 117,202,748 | |
| 1,139,854 | Institution | 1.82% | 92,886,702 | |
| 1,062,977 | Institution | 1.70% | 86,621,996 | |
| 1,030,134 | Institution | 1.65% | 83,945,620 | |
| 913,443 | Institution | 1.46% | 74,436,470 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,572,947 | Institution | 4.12% | 209,669,451 | |
| 1,062,977 | Institution | 1.70% | 86,621,996 | |
| 913,443 | Institution | 1.46% | 74,436,470 | |
| 633,874 | Institution | 1.01% | 51,654,392 | |
| 581,027 | Institution | 0.93% | 47,347,890 | |
| 501,713 | Institution | 0.80% | 40,884,592 | |
| 449,745 | Institution | 0.72% | 36,649,720 | |
| 414,868 | Institution | 0.66% | 33,807,593 | |
| 407,487 | Institution | 0.65% | 33,206,116 | |
| 342,260 | Institution | 0.55% | 27,890,767 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,556,439 | Institution | 5.69% | 289,814,214 | |
| 1,961,878 | Institution | 3.14% | 171,350,425 | |
| 1,438,480 | Institution | 2.30% | 117,221,735 | |
| 1,171,566 | Institution | 1.87% | 95,986,402 | |
| 708,784 | Institution | 1.13% | 61,905,195 | |
| 633,556 | Institution | 1.01% | 55,334,781 | |
| 541,307 | Institution | 0.87% | 44,349,283 | |
| 497,676 | Institution | 0.80% | 40,555,617 | |
| 490,394 | Institution | 0.78% | 39,962,207 | |
| 434,749 | Institution | 0.70% | 35,427,696 |
FAQ
Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 11.64% of the company's stock is held by institutional investors, 1.33% is held by insiders, and 45.25% is held by retail investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.64% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.25% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
Who owns the most shares of Protagonist Therapeutics (PTGX)?
iShares owns the most shares of Protagonist Therapeutics (PTGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.